Brind.

Soleno Therapeutics filed an offering on July 10, 2025, with TD Cowen and Cantor as joint book-running managers, and the SEC (Bangladesh) was involved.

1 report, 1 independent Updated Jul 10
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Soleno Therapeutics filed an offering on July 10, 2025, with TD Cowen and Cantor as joint book-running managers, and the SEC (Bangladesh) was involved.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped
  • GlobeNewswireSoleno Therapeutics Announces Pricing of $200 Million Public Offering of Common Stock REDWOOD CITY, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (Nasdaq: SLNO), a biop